Literature DB >> 26403203

Phosphorylation of C-terminal tyrosine residue 526 in FUS impairs its nuclear import.

Simona Darovic1, Sonja Prpar Mihevc1, Vera Župunski2, Gregor Gunčar2, Maja Štalekar1, Youn-Bok Lee3, Christopher E Shaw3, Boris Rogelj4.   

Abstract

Aberrant cytoplasmic aggregation of FUS, which is caused by mutations primarily in the C-terminal nuclear localisation signal, is associated with 3% of cases of familial amyotrophic lateral sclerosis (ALS). FUS aggregates are also pathognomonic for 10% of all frontotemporal lobar degeneration (FTLD) cases; however, these cases are not associated with mutations in the gene encoding FUS. This suggests that there are differences in the mechanisms that drive inclusion formation of FUS in ALS and FTLD. Here, we show that the C-terminal tyrosine residue at position 526 of FUS is crucial for normal nuclear import. This tyrosine is subjected to phosphorylation, which reduces interaction with transportin 1 and might consequentially affect the transport of FUS into the nucleus. Furthermore, we show that this phosphorylation can occur through the activity of the Src family of kinases. Our study implicates phosphorylation as an additional mechanism by which nuclear transport of FUS might be regulated and potentially perturbed in ALS and FTLD.
© 2015. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; FUS; Frontotemporal lobar degeneration; Nuclear import; Phosphorylation; Transportin 1

Mesh:

Substances:

Year:  2015        PMID: 26403203     DOI: 10.1242/jcs.176602

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  14 in total

1.  Modelling FUS Mislocalisation in an In Vitro Model of Innervated Human Muscle.

Authors:  Sonja Prpar Mihevc; Mojca Pavlin; Simona Darovic; Marko Živin; Matej Podbregar; Boris Rogelj; Tomaz Mars
Journal:  J Mol Neurosci       Date:  2017-06-15       Impact factor: 3.444

Review 2.  FUS and TDP-43 Phases in Health and Disease.

Authors:  Bede Portz; Bo Lim Lee; James Shorter
Journal:  Trends Biochem Sci       Date:  2021-01-11       Impact factor: 13.807

Review 3.  Role of FET proteins in neurodegenerative disorders.

Authors:  Francesca Svetoni; Paola Frisone; Maria Paola Paronetto
Journal:  RNA Biol       Date:  2016-07-14       Impact factor: 4.652

Review 4.  Pathogenesis of FUS-associated ALS and FTD: insights from rodent models.

Authors:  Matthew Nolan; Kevin Talbot; Olaf Ansorge
Journal:  Acta Neuropathol Commun       Date:  2016-09-06       Impact factor: 7.801

Review 5.  Nucleo-cytoplasmic transport defects and protein aggregates in neurodegeneration.

Authors:  Giacomo Bitetto; Alessio Di Fonzo
Journal:  Transl Neurodegener       Date:  2020-07-03       Impact factor: 8.014

Review 6.  The Role of Post-Translational Modifications on Prion-Like Aggregation and Liquid-Phase Separation of FUS.

Authors:  Shannon N Rhoads; Zachary T Monahan; Debra S Yee; Frank P Shewmaker
Journal:  Int J Mol Sci       Date:  2018-03-16       Impact factor: 5.923

7.  Differential expression of microRNAs and other small RNAs in muscle tissue of patients with ALS and healthy age-matched controls.

Authors:  Anja Kovanda; Lea Leonardis; Janez Zidar; Blaž Koritnik; Leja Dolenc-Groselj; Stanislava Ristic Kovacic; Tomaž Curk; Boris Rogelj
Journal:  Sci Rep       Date:  2018-04-04       Impact factor: 4.379

8.  The prionlike domain of FUS is multiphosphorylated following DNA damage without altering nuclear localization.

Authors:  Shannon N Rhoads; Zachary T Monahan; Debra S Yee; Andrew Y Leung; Cameron G Newcombe; Robert N O'Meally; Robert N Cole; Frank P Shewmaker
Journal:  Mol Biol Cell       Date:  2018-06-13       Impact factor: 4.138

9.  EGF receptor-mediated FUS phosphorylation promotes its nuclear translocation and fibrotic signaling.

Authors:  Manuel Chiusa; Wen Hu; Jozef Zienkiewicz; Xiwu Chen; Ming-Zhi Zhang; Raymond C Harris; Roberto M Vanacore; Jennifer A Bentz; Giuseppe Remuzzi; Ariela Benigni; Agnes B Fogo; Wentian Luo; Stavroula Mili; Matthew H Wilson; Roy Zent; Jacek Hawiger; Ambra Pozzi
Journal:  J Cell Biol       Date:  2020-09-07       Impact factor: 10.539

10.  The Impact of ALS-Associated Genes hnRNPA1, MATR3, VCP and UBQLN2 on the Severity of TDP-43 Aggregation.

Authors:  Ana Bajc Česnik; Helena Motaln; Boris Rogelj
Journal:  Cells       Date:  2020-07-28       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.